ES546908A0 - Procedimiento para la preparacion de derivados de fenilace- tonitrilo - Google Patents

Procedimiento para la preparacion de derivados de fenilace- tonitrilo

Info

Publication number
ES546908A0
ES546908A0 ES546908A ES546908A ES546908A0 ES 546908 A0 ES546908 A0 ES 546908A0 ES 546908 A ES546908 A ES 546908A ES 546908 A ES546908 A ES 546908A ES 546908 A0 ES546908 A0 ES 546908A0
Authority
ES
Spain
Prior art keywords
fenilace
tonitrile
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546908A
Other languages
English (en)
Other versions
ES8604861A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8604861A1 publication Critical patent/ES8604861A1/es
Publication of ES546908A0 publication Critical patent/ES546908A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES546908A 1984-09-12 1985-09-12 Procedimiento para la preparacion de derivados de fenilace- tonitrilo Expired ES8604861A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843433383 DE3433383A1 (de) 1984-09-12 1984-09-12 Neue phenyl-acetonitril-derivate

Publications (2)

Publication Number Publication Date
ES8604861A1 ES8604861A1 (es) 1986-03-16
ES546908A0 true ES546908A0 (es) 1986-03-16

Family

ID=6245162

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546908A Expired ES8604861A1 (es) 1984-09-12 1985-09-12 Procedimiento para la preparacion de derivados de fenilace- tonitrilo

Country Status (16)

Country Link
US (1) US4612313A (es)
EP (1) EP0175249A3 (es)
JP (1) JPS6185355A (es)
AU (1) AU562730B2 (es)
CA (1) CA1248533A (es)
CS (1) CS255894B2 (es)
DD (1) DD237504A5 (es)
DE (1) DE3433383A1 (es)
DK (1) DK413685A (es)
ES (1) ES8604861A1 (es)
FI (1) FI853343L (es)
GR (1) GR852167B (es)
HU (1) HU195644B (es)
IL (1) IL76327A (es)
SU (1) SU1508956A3 (es)
ZA (1) ZA856942B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612329A (en) * 1984-10-17 1986-09-16 Hokuriku Pharmaceutical Co., Ltd. Pharmaceutical alpha-aminoalkyl-alpha-alkylphenylacetonitriles
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
US6263940B1 (en) 1999-04-21 2001-07-24 Axon Corporation In-line continuous feed sleeve labeling machine and method
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
CA2693627C (en) 2007-06-20 2016-01-12 Milestone Pharmaceuticals Inc. Short acting phenylalkylamine calcium channel blockers and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
US4340603A (en) * 1980-08-13 1982-07-20 Interx Research Corporation Novel inotropic prodrugs
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
SU1508956A3 (ru) 1989-09-15
HU195644B (en) 1988-06-28
GR852167B (es) 1986-01-03
CS255894B2 (en) 1988-03-15
ZA856942B (en) 1986-05-28
DK413685D0 (da) 1985-09-11
HUT38302A (en) 1986-05-28
CA1248533A (en) 1989-01-10
CS652285A2 (en) 1987-07-16
US4612313A (en) 1986-09-16
AU4709985A (en) 1986-03-20
JPS6185355A (ja) 1986-04-30
DE3433383A1 (de) 1986-03-20
EP0175249A2 (de) 1986-03-26
EP0175249A3 (de) 1987-08-19
ES8604861A1 (es) 1986-03-16
DK413685A (da) 1986-03-13
FI853343A0 (fi) 1985-08-30
AU562730B2 (en) 1987-06-18
IL76327A (en) 1989-06-30
IL76327A0 (en) 1986-01-31
FI853343L (fi) 1986-03-13
DD237504A5 (de) 1986-07-16

Similar Documents

Publication Publication Date Title
ES547951A0 (es) Procedimiento para la preparacion de nuevas benzoilfenilu- reas
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
ES539486A0 (es) Procedimiento para la preparacion de compuestos cotelomeros
ES548798A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4- hidroxivalerilo
ES547924A0 (es) Procedimiento para la preparacion de bencileteres sustitui- dos
ES557428A0 (es) Procedimiento para la fabricacion de derivados nucleosidos
ES556598A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbemicina
MX159669A (es) Procedimiento para la preparacion de derivados de acilamida
MX160912A (es) Procedimiento para la preparacion de derivados de benzoato de 6-amidino-2-naftilo
MX162421A (es) Procedimiento para la preparacion de n-acilfenilalaninas
ES541906A0 (es) Procedimiento para la preparacion de glicidiloxidicetonas
ES542071A0 (es) Procedimiento para la preparacion de ergolinas
ES549677A0 (es) Procedimiento para la preparacion de derivados de acidos 1- fenil-imidazol-5-carboxilicos
MX162733A (es) Procedimiento para la preparacion de derivados amino-alcoholes
ES548651A0 (es) Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES540943A0 (es) Procedimiento para la preparacion de derivados diaminicos
ES531159A0 (es) Procedimiento para la preparacion de aminociclotiadiazinas
ES541265A0 (es) Procedimiento para la obtencion de derivados de tiocianopi- rimidina
ES546557A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
MX7420E (es) Procedimiento para la preparacion de carbamoil-lactama-n-substituida
ES542070A0 (es) Procedimiento para la preparacion de derivados de 2-(trial- quil-silil)-ergolina
ES549829A0 (es) Procedimiento para la preparacion de carbazatos
ES546923A0 (es) Procedimiento para la obtencion de derivados de salicilamida
ES545451A0 (es) Procedimiento para la fabricacion de derivados de pirrolidi-na